TORL BioTherapeutics secures $96M Series C financing to advance clinical development of TORL-1-23 for ovarian cancer.
Amount Raised
$96 Million
Round Type
Series C
Culver CityBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
TORL BioTherapeutics LLC has closed a $96 million Series C financing. Proceeds will fund the ongoing clinical development of TORL-1-23, currently in a registrational Phase 2 study for platinum-resistant ovarian cancer. Updated results of TORL-1-23 will be presented at ESMO 2025. This financing aims to push pivotal studies toward key data readouts in 2027.
Quick answer
TORL BioTherapeutics raised $96 Million in a Series C round, dated October 7, 2025. TORL BioTherapeutics is based in Culver City, California, United States.
- How much did TORL BioTherapeutics raise?
- TORL BioTherapeutics raised $96 Million in a Series C round on October 7, 2025.
- What does TORL BioTherapeutics do?
- TORL BioTherapeutics is building a preeminent biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of people with cancer..
- Where is TORL BioTherapeutics based and how big is it?
- TORL BioTherapeutics is based in Culver City, California, United States. Fundz records about 63 employees.
- Who are the decision-makers at TORL BioTherapeutics?
- Fundz holds 3 contacts at TORL BioTherapeutics, including the Chief Operating Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as TORL BioTherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Acasti raised $4M (Funding Round) on October 23, 2025.
- Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
- ISOThrive raised $8.1M on October 10, 2025.
- Santhera Pharmaceuticals raised $21M (Funding Round) on September 23, 2025.
- Os Therapies raised $3.8M on September 2, 2025.
- TNF Pharmaceuticals raised $7M on September 2, 2025.
Who to call at TORL BioTherapeutics, and when
A new round usually means TORL BioTherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TORL BioTherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TORL BioTherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TORL BioTherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TORL BioTherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TORL BioTherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.